Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Change in Receivables (2016 - 2025)

Prestige Consumer Healthcare (PBH) has 16 years of Change in Receivables data on record, last reported at -$495000.0 in Q4 2025.

  • For Q4 2025, Change in Receivables fell 107.84% year-over-year to -$495000.0; the TTM value through Dec 2025 reached $27.3 million, up 385.15%, while the annual FY2025 figure was $16.3 million, 158.26% up from the prior year.
  • Change in Receivables reached -$495000.0 in Q4 2025 per PBH's latest filing, down from $29.9 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $29.9 million in Q3 2025 and bottomed at -$27.3 million in Q2 2025.
  • Average Change in Receivables over 5 years is $3.7 million, with a median of $2.0 million recorded in 2022.
  • Peak YoY movement for Change in Receivables: crashed 824.98% in 2024, then soared 3726.04% in 2025.
  • A 5-year view of Change in Receivables shows it stood at -$12.5 million in 2021, then skyrocketed by 170.56% to $8.8 million in 2022, then rose by 29.88% to $11.4 million in 2023, then crashed by 44.74% to $6.3 million in 2024, then tumbled by 107.84% to -$495000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Receivables were -$495000.0 in Q4 2025, $29.9 million in Q3 2025, and -$27.3 million in Q2 2025.